Enlivex Therapeutics
ENLV
ENLV
21 hedge funds and large institutions have $2.87M invested in Enlivex Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Holders
21
Holding in Top 10
–
Calls
$101K
Puts
$8K
Top Buyers
| 1 | +$7.84K | |
| 2 | +$3.16K | |
| 3 | +$560 | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$64 |
Top Sellers
| 1 | -$413K | |
| 2 | -$68K | |
| 3 | -$63.6K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$27.5K |
| 5 |
Jane Street
New York
|
-$22.1K |
